Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of DS Healthcare Group Inc (NASDAQ: DSKX) violated securities laws in connection with certain financial statements.

The investigation seeks to discover if possible claims on behalf of purchasers of the securities of DS Healthcare Group Inc (NASDAQ: DSKX) concerning whether a series of statements by DS Healthcare Group Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On March 23, 2016, DS Healthcare Group revealed that there are errors in its unaudited condensed consolidated financial statements for the two fiscal quarters ended June 30, 2015 and September 30, 2015, and should no longer be relied upon due to revenue recognition errors. The Company also revealed that its Board of Directors terminated Daniel Khesin as its President and removed him as its Chairman of the Board for cause.

Following this news, DS Healthcare Group shares dropped over 60% during after-hours trading on March 23, 2016.

Based in Pompano Beach, Florida, DS Healthcare Group Inc engages in development of drug therapies for specialty pharmaceuticals and commercialization of personal care products for its consumer brands.

If you purchased shares of DS Healthcare Group Inc (NASDAQ: DSKX) on or before March 23, 2016, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185